Press Releases

  • VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference

  • VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference

  • VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016

  • VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update

  • VolitionRx Limited Schedules Third Quarter 2016 Earnings Conference Call and Business Update

  • VolitionRx Limited and Hvidovre Hospital Begin Large Prospective Clinical Study

  • VolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition

  • VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter

  • Triage Blood Test Data Presented to Leading International Experts at the World Endoscopy Organization's Colorectal Cancer Screening Committee

  • Data Presented at ESMO 2016 Demonstrates that VolitionRx Limited's Novel Blood Test for Colorectal Cancer Potentially Reduces the Need for Colonoscopy Referral by 25%